Dr. Sonpavde on Ongoing Trials With Immunotherapy for Penile Cancer

3 Visualizações
administrator
administrator
07/06/23

Guru Sonpavde, MD, director of Bladder Cancer at the Dana-Farber Cancer Institute, ongoing trials investigating immunotherapy for patients with penile cancer.

  • Categoria

Mostre mais
0 Comentários Ordenar por

    Nenhum comentário encontrado

    Comentários do Facebook

    A seguir

    Role of immunotherapy in the management of mesothelioma
    00:03:34
    Role of immunotherapy in the management of mesothelioma
    administrator
    2 Visualizações
    Immunotherapy for mesothelioma
    00:03:33
    Immunotherapy for mesothelioma
    administrator
    1 Visualizações
    PLATO and immunotherapy trials in anal cancer
    00:04:05
    PLATO and immunotherapy trials in anal cancer
    administrator
    1 Visualizações
    Future developments in immunotherapy for treatment of biliary tract cancer
    00:02:05
    Future developments in immunotherapy for treatment of biliary tract cancer
    administrator
    5 Visualizações
    Landmark colorectal cancer trials: Summary
    00:18:28
    Landmark colorectal cancer trials: Summary
    administrator
    1 Visualizações
    Clinical Trials for Recurrent and Metastatic Anal Cancer with Cathy Eng, MD, FACP, FASCO
    00:13:35
    Clinical Trials for Recurrent and Metastatic Anal Cancer with Cathy Eng, MD, FACP, FASCO
    administrator
    2 Visualizações
    Immunotherapy Advances the Treatment Landscape of Endometrial Cancers
    00:01:35
    Immunotherapy Advances the Treatment Landscape of Endometrial Cancers
    administrator
    1 Visualizações
    Podcast: New immunotherapy for endometrial cancer patients | OSUCCC – James
    00:19:55
    Podcast: New immunotherapy for endometrial cancer patients | OSUCCC – James
    administrator
    3 Visualizações
    Immunotherapy Advances the Treatment Landscape of Endometrial Cancers
    00:01:35
    Immunotherapy Advances the Treatment Landscape of Endometrial Cancers
    administrator
    2 Visualizações
    Improving responses to immunotherapy for patients with endometrial cancer
    00:01:42
    Improving responses to immunotherapy for patients with endometrial cancer
    administrator
    2 Visualizações
    Promising new treatments for sarcomas: immunotherapy and fusion targeted compounds
    00:07:40
    Promising new treatments for sarcomas: immunotherapy and fusion targeted compounds
    administrator
    3 Visualizações
    Understanding Clinical Trials and How They Fit in Treating Appendix Cancer with Dr. Kothari
    01:28:48
    Understanding Clinical Trials and How They Fit in Treating Appendix Cancer with Dr. Kothari
    administrator
    2 Visualizações
    Campaign for NHI to fund immunotherapy for head and neck cancer patients
    00:02:07
    Campaign for NHI to fund immunotherapy for head and neck cancer patients
    administrator
    24 Visualizações
    Clinical Trials and Latest Research for Cutaneous T-Cell Lymphoma (CTCL)
    00:04:41
    Clinical Trials and Latest Research for Cutaneous T-Cell Lymphoma (CTCL)
    administrator
    16 Visualizações
    7 Year Old Girl Beats Acute Lympoblastic Leukemia: Emily Whitehead's Immunotherapy Story
    00:05:37
    7 Year Old Girl Beats Acute Lympoblastic Leukemia: Emily Whitehead's Immunotherapy Story
    administrator
    13 Visualizações
    Benny's Ongoing Battle with Acute Lymphoblastic Leukemia
    00:03:39
    Benny's Ongoing Battle with Acute Lymphoblastic Leukemia
    administrator
    2 Visualizações
    Kristin & Benny: Immunotherapy & Acute Lymphoblastic Leukemia
    00:05:07
    Kristin & Benny: Immunotherapy & Acute Lymphoblastic Leukemia
    administrator
    4 Visualizações
    Immunotherapy delivered by blinatumomab improves survival in acute lymphoblastic leukemia patients
    00:04:35
    Immunotherapy delivered by blinatumomab improves survival in acute lymphoblastic leukemia patients
    administrator
    3 Visualizações
    Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227
    00:02:44
    Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227
    administrator
    4 Visualizações